Clinical Trials in Arizona

Showing 15001-15020 of 16,770 trials

Pancreatic Cancer Serum and DNA Repository

NCT00296114

To prospectively collect serum and DNA samples from subjects with pancreatic cancer, pancreatitis, liver disease, and from healthy and at-risk volunteers in order to identify novel biomarkers for early diagnosis, differential diagnosis, stage, natural history of the disease, response to treatment, and to identify novel targets for therapeutic interventions. In particular:

Pancreas Cancer

Pancreatic Cancer Research Team690 participantsStarted Feb 2004

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +7 more locations

COMPLETEDPhase 135 miles

A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 1,000 mg) in Healthy Volunteers

NCT01454622

The purpose of this study is to evaluate the bioequivalence of fixed dose combination (FDC) tablets of canagliflozin and metformin immediate release (IR) in comparison with the individual components of canagliflozin and metformin IR.

Healthy

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.64 participantsStarted Sep 2011

Tempe, Arizona, United States

Pancreatic Cancer Serum and DNA Repository

A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 1,000 mg) in Healthy Volunteers

Find Trials by Condition in Arizona

SoundBite Hearing System 24 Month Multi Site Patient Use Study

Doxycycline and OA Progression

Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

Treatment of Moderate to Severe Facial Acne Vulgaris

Cognitive REmediation After Trauma Exposure Trial = CREATE Trial

A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD)

Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations

Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer

Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero®.

Advisa MRI Clinical Study

Drug Eluting Stent Registry of Thrombosis

A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118

Safety Study of Post Tonsillectomy Ibuprofen Use in Adults

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors